<table frame="void" id="icae88506-dabb-4d8a-8496-b7617c8fe114" width="638" xmlns="urn:hl7-org:v3" xmlns:v="http://validator.pragmaticdata.com/result" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<thead>
<tr>
<td align="center" colspan="3" stylecode="BotruleLruleRruleToprule" valign="top">
<content stylecode="bold">Table 7. Erosive Esophagitis Patient Healing Rates </content>
</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top"></td>
<td align="center" colspan="2" stylecode="BotruleLruleRruleToprule" valign="top"> Healed / Evaluable </td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top"></td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top"> Placebo* <br/>n=229 </td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top"> Ranitidine Tablets, USP<br/>150 mg q.i.d.*<br/>n=215 </td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">Week 4</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">43/198 (22%)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">96/206 (47%) <sup>†</sup>
</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">Week 8</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">63/176 (36%)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">142/200 (71%) <sup>†</sup>
</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">Week 12</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">92/159 (58%)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">162/192 (84%) <sup>†</sup>
</td>
</tr>
</tbody>
</table>